To evaluate docosahexaenoic acid baseline reference ranges in Indian pregnant population and establishing the preclinical data in the treatment of preterm birth. - DCNPW

Department of Pharmaceutical Sciences Guru Nanak Dev University Amritsar0 个研究点目标入组 164 人开始时间: 待定最近更新: 2024年4月1日

试验速览

暂无简介。

•Women were eligible for enrollment if they were between 12 and 24 week of gestation between 16 and 40 year of age and planning to deliver at a same hospital

•You have an active infection or other serious condition such as cardiac disease, cancer, lupus, hepatitis, HIV/AIDS, or a diagnosed alcohol or chemical dependency.
•Subjects were excluded if they were carrying more than one fetus.
•Had preexisting diabetes mellitus or systolic blood pressure 140 mm Hg at enrollment.
•Had any serious health condition likely to affect the prenatal or postnatal growth and development of their offspring,
•You are unable or unwilling to DHA supplement.
•You have had a yellow fever vaccination within the last 30 days or plan to have it.

发起方

Department of Pharmaceutical Sciences Guru Nanak Dev University Amritsar